# Risk Stratification of Nodal PTCL

> **NCT03040206** · — · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 405 (actual)

## Conditions studied

- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Angioimmunoblastic T-cell Lymphoma
- Anaplastic Large Cell Lymphoma, ALK-negative

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03040206
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-12
- **Target enrollment:** 405 (ACTUAL)
- **Last updated:** 2019-08-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03040206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03040206, "Risk Stratification of Nodal PTCL". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03040206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*